{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:36Z","timestamp":1794330336547,"version":"4.9.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1136\/ard.2003.011379","type":"journal-article","created":{"date-parts":[[2004,9,10]],"date-time":"2004-09-10T19:58:49Z","timestamp":1094846329000},"page":"1279-1283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["A disease activity score for polymyalgia rheumatica"],"prefix":"10.1016","volume":"63","author":[{"given":"B F","family":"Leeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H A","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.011379_bib1","first-page":"789","article-title":"Polymyalgia rheumatica and temporal arteritis","volume":"62","author":"Epperly","year":"2000","journal-title":"Fam Physician"},{"issue":"Suppl 20","key":"10.1136\/ard.2003.011379_bib2","first-page":"S9","article-title":"Epidemiology of polymyalgia rheumatica","volume":"18","author":"Cimmino","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2003.011379_bib3","first-page":"68","article-title":"A 24-year-old man with symptoms and signs of polymyalgia rheumatica","volume":"47","author":"Whittaker","year":"1998","journal-title":"J Fam Pract"},{"key":"10.1136\/ard.2003.011379_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinte.159.6.577","article-title":"Corticosteroid requirements in polymyalgia rheumatica","volume":"159","author":"Weyand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2003.011379_bib5","first-page":"1333","article-title":"Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis","volume":"26","author":"Proven","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.011379_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.011379_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.40.1.1","article-title":"Prognosis and management of polymyalgia rheumatica","volume":"40","author":"Jones","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.011379_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.011379_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3949\/ccjm.52.2.155","article-title":"Masked presentation of giant-cell arteritis","volume":"52","author":"Wilke","year":"1985","journal-title":"Cleve Clin Q"},{"key":"10.1136\/ard.2003.011379_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2169\/internalmedicine1962.28.452","article-title":"Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria","volume":"28","author":"Nobunaga","year":"1989","journal-title":"Jpn J Med"},{"key":"10.1136\/ard.2003.011379_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/ard.2002.002618","article-title":"EULAR response criteria for polymyalgia rheumatica. Results of an initiative of the European collaborating Polymyalgia Rheumatica group (Subcommittee of ESCISIT (EULAR Standing Committee on Clinical Trials Including Therapeutical Trials))","volume":"62","author":"Leeb","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.011379_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2003.011379_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"Suppl II","key":"10.1136\/ard.2003.011379_bib14","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/ard.60.90003.iii2","article-title":"Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002)","volume":"61","author":"Furst","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.011379_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1207\/S15327752JPA8001_18","article-title":"Starting at the beginning: an introduction to coefficient alpha and internal consistency","volume":"80","author":"Streiner","year":"2003","journal-title":"J Personality Assessment"},{"key":"10.1136\/ard.2003.011379_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.48.8.667","article-title":"Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica\/giant cell arteritis on presentation and during follow up","volume":"48","author":"Kyle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.011379_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.1997.00440240081012","article-title":"Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome","volume":"157","author":"Gonzalez-Gay","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2003.011379_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2000.8366","article-title":"Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study","volume":"30","author":"Cantini","year":"2000","journal-title":"Semin Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724401295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724401295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.011379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T22:46:28Z","timestamp":1736117188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724401295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0003496724401295"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.011379","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A disease activity score for polymyalgia rheumatica","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.011379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}